Literature DB >> 7548679

Polymorphic variation in the human protein C (PROC) gene promoter can influence transcriptional efficiency in vitro.

D Scopes1, L P Berg, M Krawczak, V V Kakkar, D N Cooper.   

Abstract

The haplotype frequencies of two closely linked diallelic polymorphisms in the protein C(PROC) gene promoter were determined in the British population. In principle, differences in transcription efficiency between PROC promoter haplotypes could represent an additional risk factor in determining whether or not an individual already predisposed to venous thrombosis will come to clinical attention. In order to explore this postulate, transient transfection of human hepatoma cells with PROC promoter-luciferase reporter gene constructs was performed in vitro. In HepG2 cells, the T.....A haplotype exhibited at least a two-fold higher transcription efficiency than the C.....G haplotype. A sample of British protein C deficiency patients with recurrent venous thrombosis was then allelotyped by a combination of oligonucleotide discriminant hybridization and DNA sequencing. The frequency of the low expressing C.....G haplotype was found to be slightly yet not significantly higher in these patients (0.43) than in controls (0.35).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548679     DOI: 10.1097/00001721-199506000-00004

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.

Authors:  A P Reiner; C L Carty; N S Jenny; C Nievergelt; M Cushman; D J Stearns-Kurosawa; S Kurosawa; L H Kuller; L A Lange
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

2.  Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia.

Authors:  Alexander Binder; Georg Endler; Sandra Rieger; Gotho Geishofer; Bernhard Resch; Christine Mannhalter; Werner Zenz
Journal:  Hum Genet       Date:  2007-06-14       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.